You are here

  • Home
  • Archive
  • Volume 33, Issue 8
  • A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers

Article metrics

Article menu
Download PDFPDF
Original research
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers

 

Online download statistics by month:

Online download statistics by month: June 2023 to September 2024

AbstractFullPdf
Jun 2023324103
Jul 20238032418
Aug 20236483513
Sep 2023210117
Oct 202322475
Nov 2023204128
Dec 202317545
Jan 202421877
Feb 202421074
Mar 20242291211
Apr 202414131
May 202416045
Jun 202416743
Jul 202412495
Aug 20248811
Sep 20244300
Total396815096